Cargando…
Azathioprine/immune-globulin/steroids: COVID-19 and treatment failure in myasthenia gravis: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298970/ http://dx.doi.org/10.1007/s40278-021-99386-x |
Ejemplares similares
-
Azathioprine: Myasthenia gravis crisis secondary to COVID-19 pneumonitis: case report
Publicado: (2021) -
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis
por: Heckmann, Jeannine M, et al.
Publicado: (2011) -
Azathioprine/immune-globulin/methylprednisolone/romiplostim: Lack of efficacy: case report
Publicado: (2021) -
Azathioprine/rituximab: Liver toxicity, myasthenia crisis and COVID-19: case report
Publicado: (2021) -
Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report
por: Finsterer, Josef, et al.
Publicado: (2010)